Pain Reliever

Product NDC: 50844-175
11-digit product format: 508440175
Labeler code: 50844
Product ID: 50844-175_195fd310-b148-478a-aad5-2894a0ace24c
Type: HUMAN OTC DRUG
Nonproprietary name: Acetaminophen
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: L.N.K. International, Inc.
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 1993-04-02
Substance: ACETAMINOPHEN
Active strength: 500 mg/1
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded package	package	50844-175	50844-175-08	D	Discontinued by firm	2026-10-15
excluded package	package	50844-175	50844-175-10	D	Discontinued by firm	2026-10-15
excluded package	package	50844-175	50844-175-94	D	Discontinued by firm	2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 28 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Package NDC, Snapshot table
Captured / source date	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	50844-175-08	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	50844-175-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	50844-175-08	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	50844-175-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	50844-175-08	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	50844-175-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	50844-175-08	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	50844-175-10	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	50844-175-08	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	50844-175-10	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	50844-175-08	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	50844-175-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	50844-175-08	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	50844-175-10	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	50844-175-08	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	50844-175-10	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	50844-175-08	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	50844-175-10	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	50844-175-12	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	50844-175-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	50844-175-10	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	50844-175-12	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	50844-175-08	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	50844-175-10	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	50844-175-12	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	50844-175-08	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	50844-175-10	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	50844-175-12	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Pain Reliever
Brand name suffix: Extra Strength
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ACETAMINOPHEN	500 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
362O9ITL9D	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
198440	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
8fed703a-9de2-4c76-a783-fcf004f9b890	Available on FDA.report

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
50844-175-08	Pain RelieverExtra Strength	1 in 1 CARTON	TABLET, FILM COATED	1	14
50844-175-08	Pain RelieverExtra Strength	24 in 1 BOTTLE, PLASTIC	TABLET, FILM COATED	24	14
50844-175-10	Pain RelieverExtra Strength	1 in 1 CARTON	TABLET, FILM COATED	1	14
50844-175-10	Pain RelieverExtra Strength	40 in 1 BOTTLE, PLASTIC	TABLET, FILM COATED	40	14
50844-175-12	Pain RelieverExtra Strength	1 in 1 CARTON	TABLET, FILM COATED	1	14
50844-175-12	Pain RelieverExtra Strength	100 in 1 BOTTLE, PLASTIC	TABLET, FILM COATED	100	14
50844-175-94	Pain RelieverExtra Strength	100 in 1 BOTTLE, PLASTIC	TABLET, FILM COATED	100	14

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ACETAMINOPHEN	ACTIVE INGREDIENT	362O9ITL9D	EXTRA STRENGTH PAIN RELIEVER (ACETAMINOPHEN) TABLET [L.N.K. INTERNATIONAL, INC.]	2
ACETAMINOPHEN	ACTIVE MOIETY	362O9ITL9D	EXTRA STRENGTH PAIN RELIEVER (ACETAMINOPHEN) TABLET [L.N.K. INTERNATIONAL, INC.]	2
CASTOR OIL	INACTIVE INGREDIENT	D5340Y2I9G	EXTRA STRENGTH PAIN RELIEVER (ACETAMINOPHEN) TABLET [L.N.K. INTERNATIONAL, INC.]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	EXTRA STRENGTH PAIN RELIEVER (ACETAMINOPHEN) TABLET [L.N.K. INTERNATIONAL, INC.]	2
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	EXTRA STRENGTH PAIN RELIEVER (ACETAMINOPHEN) TABLET [L.N.K. INTERNATIONAL, INC.]	2
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	EXTRA STRENGTH PAIN RELIEVER (ACETAMINOPHEN) TABLET [L.N.K. INTERNATIONAL, INC.]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	EXTRA STRENGTH PAIN RELIEVER (ACETAMINOPHEN) TABLET [L.N.K. INTERNATIONAL, INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50844-175	PAIN RELIEVER EXTRA STRENGTH (ACETAMINOPHEN) TABLET, FILM COATED [L.N.K. INTERNATIONAL, INC.]	14	Current NDC, Legacy NDC, 7 package rows	20250116_8fed703a-9de2-4c76-a783-fcf004f9b890.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 35 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Goodys Cool Orange Headache	ACETAMINOPHEN AND ASPIRIN AND CAFFEINE	Medtech Products Inc.	31212c97-9975-427e-bc3d-f7125f30299a	2025-10-23	Warnings	Exact identifier application number: M013
BC Arthritis	ASPIRIN AND CAFFEINE	Medtech Products Inc.	3a85be2d-6548-4de5-8109-60e1ca2bfca3	2025-10-23	Warnings	Exact identifier application number: M013
Goodys Extra Strength	ACETAMINOPHEN, ASPIRIN, AND CAFFEINE	Medtech Products Inc.	d4325b17-23bc-44ac-868d-bb0886853a73	2025-10-23	Warnings	Exact identifier application number: M013
BC	ASPIRIN AND CAFFEINE	Medtech Products Inc.	226173d4-b6d5-4fe6-b24e-1cc5d1b31c88	2025-10-23	Warnings	Exact identifier application number: M013
BC MAX	ASPIRIN, ACETAMINOPHEN, CAFFEINE	Medtech Products Inc.	1e2a07ab-23e6-49b4-a676-212dc6880f14	2025-10-23	Warnings	Exact identifier application number: M013
Ecotrin Regular Strength	ASPIRIN	Medtech Products Inc.	36cb530b-25b2-4f62-a25d-aa04360815a8	2025-10-23	Warnings	Exact identifier application number: M013
Childrens Pain and Fever	ACETAMINOPHEN	TOPCO ASSOCIATES LLC	bbc367cc-6c79-498e-8fca-1347e6ea1a8c	2025-10-22	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	Rugby Laboratories	b16ed4ef-689c-4df2-ab6c-207aa8b9925d	2025-10-22	Warnings	Exact identifier application number: M013
Tension Headache Relief	ACETAMINOPHEN, CAFFEINE	TIME CAP LABS INC	05364eb4-07a1-a4d9-e063-6294a90a47e5	2025-10-21	Warnings	Exact identifier application number: M013
Acetaminophen, Aspirin, Caffeine	ACETAMINOPHEN, ASPIRIN, CAFFEINE	CVS Pharmacy, Inc.	6deb854f-863e-24ad-e053-2991aa0afb17	2025-10-21	Warnings	Exact identifier application number: M013
BackAid	ACETAMINOPHEN, CAFFEINE	Kobayashi Healthcare International, Inc.	25db6bb5-96b6-4be1-e063-6294a90a2300	2025-10-21	Warnings	Exact identifier application number: M013
M-PAP	ACETAMINOPHEN	Method Pharmaceuticals, LLC	1539dc44-15a0-153b-e063-6294a90a9d45	2025-10-21	Warnings	Exact identifier application number: M013
M-PAP	ACETAMINOPHEN	Method Pharmaceuticals, LLC	3d1bb61c-15db-4eba-aba9-cfbcbc7b30e0	2025-10-21	Warnings	Exact identifier application number: M013
Walgreens Antacid Pain Relief Extra Strength	ASPIRIN, CITRIC ACID, SODIUM BICARBONATE	Walgreens	b60df498-07db-500b-e053-2a95a90aff6a	2025-10-17	Warnings	Exact identifier application number: M013
Equate Effervescent Antacid and Pain Relief	ASPIRIN, CITRIC ACID, SODIUM BICARBONATE	Walmart	6271b34b-55a0-40a8-e053-2a91aa0acb22	2025-10-17	Warnings, Adverse reactions	Exact identifier application number: M013
Xesso Neo	BENZOCAINE	PREMIUM NATURAL COSMETICS INC	163f32cd-4e51-950a-e063-6394a90a4816	2025-10-17	Warnings	Exact identifier application number: M013
Menstrual Complete Maximum Strength	ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE	CHAIN DRUG MARKETING ASSOCIATION INC	913d8bdb-7644-464c-b9a6-55387ff12059	2025-10-17	Warnings	Exact identifier application number: M013
Alka-Seltzer Hangover Relief	ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE	Bayer HealthCare LLC.	dc235b06-999e-221d-e053-2a95a90a0ce1	2025-10-16	Warnings	Exact identifier application number: M013
Aspirin 81mg	ASPIRIN ENTERIC COATED TABLETS 81MG	VITANE PHARMACEUTICALS, INC	41386de5-5857-efab-e063-6294a90afd9c	2025-10-15	Warnings	Exact identifier application number: M013
Aspirin 81mg	ASPIRIN ENTERIC COATED TABLETS 81MG	VITANE PHARMACEUTICALS, INC	4138d4c0-baa5-1f20-e063-6394a90a788f	2025-10-15	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
198440	acetaminophen 500 MG Oral Tablet	PSN	8fed703a-9de2-4c76-a783-fcf004f9b890	14
198440	acetaminophen 500 MG Oral Tablet	SCD	8fed703a-9de2-4c76-a783-fcf004f9b890	14
198440	APAP 500 MG Oral Tablet	SY	8fed703a-9de2-4c76-a783-fcf004f9b890	14

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
50844-175-08	50844017508	1 BOTTLE, PLASTIC in 1 CARTON (50844-175-08) > 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC	1993-04-02	0000-00-00	No	No	Current
50844-175-10	50844017510	1 BOTTLE, PLASTIC in 1 CARTON (50844-175-10) > 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC	1993-04-02	0000-00-00	No	No	Current
50844-175-12	50844017512	1 BOTTLE, PLASTIC in 1 CARTON (50844-175-12) / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC	1993-04-02	0000-00-00	No	No	Current
50844-175-94	50844017594	100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-175-94)	1993-04-02	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Pain Reliever	L.N.K. International, Inc. \| LNK International, Inc.	2026-01-07	HUMAN OTC DRUG LABEL	15